CAPZA1, HLA-E, IMPA2, NFE2L3, PLEKHO1, SIGLEC1, and UBE2Z were expressed at higher levels in tumor tissues, whereas EMX2, FGL2, FUCA1, and GRB2 were expressed at lower levels in tumor tissues (Figure 6(a)). The gene discussed is NFE2L3; the disease is neoplasm.